Autonomic symptoms in @entity101 XXXX with post-acute minor @entity385 .

@entity1 @entity64 @entity308 @entity101 @entity191 @entity5433 @entity551 @entity65 @entity385
BACKGROUND: Most studies regarding @entity5433 in @entity385 are limited to heart rate and blood pressure changes during the acute phase. However, there are few data on quantitative assessment of autonomic symptoms. We sought to assess autonomic symptoms in @entity101 @entity385 @entity1 . METHODS: In 100 @entity101 @entity1 (45 with symptomatic @entity385 (6 months after @entity64 onset) and 55 without @entity64 ), we assessed autonomic symptoms using the Scale for Outcomes in @entity191 (SCOPA-AUT). RESULTS: The age (mean  standard deviation) for the @entity64 group was 66  12 and 63  15 for the without @entity64 group (P=0.8). @entity551 occurred in 3.6% of the @entity64 group and 4.4% in the group without @entity64 . The total SCOPA-AUT score was higher in the @entity64 group compared with the group without @entity64 (P=0.001). Domain scores for gastrointestinal (P=0.001), urinary (P=0.005) and cardiovascular (P=0.001) were higher in the @entity64 group. No differences were found when comparing the total SCOPA-AUT scores for @entity64 subtypes (P=0.168) and for lateralization (P=0.6). SCOPA AUT scores were correlated with @entity308 scores (P=0.001) but not with @entity64 severity (P=0.2). CONCLUSION: Autonomic symptoms, especially, @entity65 , were significantly increased in @entity101 @entity1 with minor @entity385 . Symptoms were associated with @entity308 but not with the characteristic of the @entity64 .
